Active Ingredient(s):Belzutifan FDA Approved: * August 13, 2021 Pharm Company: *MERCK SHARP DOHME Category:Cancer
Belzutifan, sold under the brand name Welireg, is a medication used for the treatment of von Hippel–Lindau disease-associated renal cell carcinoma. It is taken by mouth.
The most common side effects include decreased hemoglobin, anemia, fatigue, increased creatinine, headache, dizziness, increased glucose, and nausea.
Belzutifan is an hy...
* May have multiple approval dates, manufacturers, or labelers.